| UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
|---|---|---|---|---|
| C6KSS5 (LRR2_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Protein PFF0380w; | |
| O77384 (LRR4_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Protein PFC0760c; | |
| Q8IJP2 (MAP1B_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Methionine aminopeptidase 1b; PfMetAP1b; | |
| Q8IDF3 (MCA1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Metacaspase-1; PfMCA1; Large subunit p20; Small subunit p10; | |
| Q8IL84 (MCA2_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Metacaspase-2; PfMCA2; | |
| Q8ILT4 (MCA3_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Metacaspase-3; PfMCA3; | |
| Q7K6A5 (MDR_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Multidrug resistance protein 1; P-glycoprotein homolog; | |
| Q8I397 (MFRN_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Putative mitoferrin; Mitochondrial carrier protein MRS3; | |
| Q8I3Z1 (MLRR1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | MATH and LRR domain-containing protein PFE0570w; | |
| Q8IJK4 (MNMA_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Putative tRNA-specific 2-thiouridylase; | |
| Q8IIG4 (MRS2_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Mitochondrial inner membrane magnesium transporter MIT1; | |
| P50498 (MSA2_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Merozoite surface protein 2; 45 kDa merozoite surface antigen; Merozoite surface antigen 2; | |
| P62368 (ISPF_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase, apicoplast; PfIspF; | |
| Q8I295 (ISPH_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | 4-hydroxy-3-methylbut-2-enyl diphosphate reductase, apicoplast; | |
| Q8IBP3 (ITPA_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Inosine triphosphate pyrophosphatase; Non-canonical purine NTP pyrophosphatase; Non-standard purine NTP pyrophosphatase; Nucleoside-triphosphate diphosphatase; Nucleoside-triphosphate pyrophosphatase; XTP/dITP diphosphatase; | |
| Q8IJV6 (KAD1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Adenylate kinase 1; | |
| Q8IB06 (KAD2_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Adenylate kinase 2; | |
| Q8I1T1 (KAD3_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | GTP:AMP phosphotransferase; | |
| Q8I236 (KAD6_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Adenylate kinase isoenzyme 6 homolog; Dual activity adenylate kinase/ATPase; PfAKLP1; | |
| C0H582 (KADL_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Inactive adenylate kinase; Adenylate kinase-like protein 2; | |
| Q8IHZ9 (KC1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Casein kinase I; Casein kinase 1; | |
| Q8I5E6 (KCH1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Potassium channel K1; | |
| Q8IKI3 (KCH2_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Potassium channel K2; | |
| Q8I719 (KGP_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | cGMP-dependent protein kinase; PfPKG; | |
| Q8I4S1 (KTHY_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Thymidylate kinase; Thymidine monophosphate kinase; Thymidylate/guanylate kinase; | |
| Q8IDQ0 (LIPA_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Lipoyl synthase, apicoplast; Lipoate synthase; Lipoic acid synthase; | |
| Q8IEG9 (LIPLA_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Lipoate--protein ligase 1; | |
| Q8I2S0 (LIPLB_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Inactive lipoate--protein ligase 2; | |
| Q8IIP1 (COQ4_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial; 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase; Coenzyme Q biosynthesis protein 4 homolog; | |
| Q8IK85 (COX11_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Cytochrome c oxidase assembly protein COX11, mitochondrial; | |
| Q8IBZ9 (CRT_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Chloroquine resistance transporter; PfCRT; Probable transporter cg10; | |
| Q7K740 (CSP_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Circumsporozoite protein; Circumsporozoite protein C-terminus; | |
| Q8IFM8 (CYRPA_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Cysteine-rich protective antigen; Inactive sialidase CyRPA; | |
| C0H4E4 (DCXH_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Doublecortin domain-containing protein; PfApicortin; | |
| Q8IBN8 (DDX31_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | ATP-dependent DNA helicase DDX31; Probable ATP-dependent RNA helicase DDX31; | |
| Q8IAR5 (DEGPH_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Serine protease DegP homolog; | |
| Q8I467 (CADF1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Cofilin/actin-depolymerizing factor homolog 1; | |
| Q8ID92 (CADF2_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Cofilin/actin-depolymerizing factor homolog 2; | |
| P62203 (CALM_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Calmodulin; | |
| Q8I2A6 (CBPZ1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Putative zinc carboxypeptidase; | |
| Q8IHS4 (CCD1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Coiled-coil domain-containing protein PF3D7_1144200; | |
| P46468 (CDAT_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Putative cell division cycle ATPase; | |
| P61075 (CDK2H_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Cyclin-dependent kinase 2 homolog; Cell division control protein 2 homolog; Protein kinase 5; cdc2-related kinase 2; | |
| P62344 (CDPK1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Calcium-dependent protein kinase 1; PfCDPK1; | |
| Q8ICR0 (CDPK2_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Calcium-dependent protein kinase 2; PfCDPK2; | |
| Q9NJU9 (CDPK3_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Calcium-dependent protein kinase 3; PfCDPK3; | |
| Q8IBS5 (CDPK4_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Calcium-dependent protein kinase 4; PfCDPK4; | |
| A0A5K1K8H0 (CDPK5_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Calcium-dependent protein kinase 5; PfCDPK5; | |
| O96188 (CERI1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Rhoptry surface protein CERLI1; Cytosolically exposed rhoptry leaflet interacting protein 1; Rhoptry apical surface protein 2; | |
| Q8I1X7 (CERI2_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Rhoptry surface protein CERLI2; Ag-1 blood stage membrane protein homolog; Cytosolically exposed rhoptry leaflet interacting protein 2; |
Plasmodium falciparum is a protozoan parasite that resides in human red blood cells, but can also infect the brain and liver. P. falciparum is one of the species of Plasmodium that causes malaria in humans. It has a complex life-cycle requiring both human and female Anopheles mosquito. P. falciparum is responsible for the disease's most dangerous form, malignant or falciparum malaria, which has the highest complication rates and mortality.
With more than 200 million cases and 400,000 deaths from malaria worldwide, P. falciparum (causing roughly 50% of the cases) has been the focus of malaria research for decades.
The genome of P. falciparum was first sequenced in 2002.
From left to right: i) The number of proteins in the reference proteome of Plasmodium falciparum, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Plasmodium falciparum for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Plasmodium falciparum, please visit UniProtKB.
You can easily download the latest protein sequences for Plasmodium falciparum proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2026_01 that was used for the most up to date SWISS-MODEL Repository.
| Proteins in proteome | Sequences modelled | Models |
| 5,361 | 3,866 | 6,835 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Plasmodium falciparum reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Plasmodium falciparum proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
| Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 9-mer | 10-mer | 12-mer | 14-mer | 16-mer | 20-mer | 21-mer | 24-mer | 32-mer | 40-mer | 60-mer |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6,165 | 460 | 36 | 68 | 9 | 49 | 9 | 5 | 1 | 4 | 10 | 3 | 3 | 1 | 1 | 3 | 2 | 3 | 3 |
